| Literature DB >> 34040975 |
Mikihisa Onigahara1, Shintaro Yanazume1, Takashi Ushiwaka1, Shinichi Togami1, Masaki Kamio1, Hiroaki Kobayashi1.
Abstract
Cervical elongation in patients with pelvic organ prolapse (POP), who previously underwent laparoscopic sacrocolpopexy (LSC), is not fully understood. We report a case of a second surgery for endometrial cancer complicated with POP recurrence, which seemed to be related to cervical elongation following LSC. A 65-year-old woman was referred for invasive treatment following LSC. Although preoperative endometrial cytology was negative, the resected uterine specimen revealed endometrioid carcinoma. The patient also had complications of cervical prolapse with cystocele Stage III. Repeat surgery was performed with a trachelectomy, anterior-posterior colporrhaphy, and vaginal apex suspension. Mesh had been adequately sutured to the upper cervix in the previous surgery, and the resected cervix was elongated up to 9 cm. Cervical elongation may be correlated with the inaccurate preoperative endometrial examination, and it may also promote POP recurrence leading to a poorly supported pelvic floor. We suggest that cervical elongation should be identified before POP surgery. Copyright:Entities:
Keywords: Cervical elongation; endometrial cancer; laparoscopic sacrocolpopexy; pelvic organ prolapse
Year: 2021 PMID: 34040975 PMCID: PMC8140543 DOI: 10.4103/GMIT.GMIT_114_19
Source DB: PubMed Journal: Gynecol Minim Invasive Ther ISSN: 2213-3070
Figure 1(a) The cervix was re-prolapsed, exceeding the vaginal introitus, and also complicated with cystocele. (b) The resected cervix revealed cervical elongation up to 9 cm
Reported cases of diagnosed malignancy following uterine prolapse surgery in resected uterine specimens
| Author, years | Age (y) | Number of cases | Atypical bleeding | Preoperative investigation | Prolapse surgery procedure | Collection method | FIGO stage | Histology | Additional treatment | Metastasis | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Yin | 2/372 | ||||||||||
| Case 1 | NA | NA | NA | NA | NA | 1A | Endometrioid ca | NA | None | NA | |
| Case 2 | NA | NA | NA | NA | NA | 1A | Endometrioid ca, Grade 2 | NA | None | NA | |
| Frick | 2/644 | ||||||||||
| Case 1 | NA | - | NA | Hysterectomy | NA | 1A | Endometrioid ca, Grade 3 | None | NA | NA | |
| Case 2 | NA | + | NA | Hysterectomy | NA | 1A | Endometrioid ca, Grade 3 | None | NA | NA | |
| Renganathan | 4/517 | ||||||||||
| Case 1 | 65 | - | NA | VH, PFR | Trans-vaginal | 1B | Endometrioid ca | None | NA | NA | |
| Case 2 | 74 | - | NA | VH, PFR | Trans-vaginal | 1B | Endometrioid ca | None | NA | NA | |
| Case 3 | 62 | - | NA | VH, PFR, and TVT | Trans-vaginal | 1A | Endometrioid ca | Laparoscopic BSO | NA | NA | |
| Case 4 | 71 | - | NA | VH, PFR, and TVT | Trans-vaginal | 2B | Endometrioid ca | Laparoscopic BSO, PLNDx, and Vault brachytherapy | NA | NA | |
| Ramm | 5/708 | ||||||||||
| Case 1 | 71 | - | Endometrial biopsy- benign | VH, BSO, and apical suspension | Trans-vaginal | NA | Endometrioid ca, grade 1 | None | NA | NED | |
| Case 2 | 52 | - | none | VH, apical suspension | Trans-vaginal | NA | Endometrioid ca, grade 1 | None | NA | NED | |
| Case 3 | 71 | - | Endometrial biopsy- benign | VH, BSO, and apical suspension | Trans-vaginal | NA | Endometrioid ca, grade 1 | None | NA | NED | |
| Case 4 | 60 | - | Endometrial biopsy- benign | VH, BSO, and apical suspension | Trans-vaginal | NA | Endometrioid ca, grade 2 | None | NA | NED | |
| Case 5 | 55 | - | Endometrial stripe | VH, BSO, and apical suspension | Trans-vaginal | NA | Leiomyosarcoma | Laparotomy, CT | NA | DOD at 7 months | |
| WAN | 3/640 | ||||||||||
| Case 1 | NA | - | Endometrial sampling- complex hyperplasia with atypia | VH | Trans-vaginal | 1A | Endometrioid ca, grade 1 | Laparoscopic BSO | None | Good | |
| Case 2 | NA | + | NA | VH | Trans-vaginal | 1A | Endometrioid ca, grade 2 | None | None | Good | |
| Case 3 | NA | + | NA | VH | Trans-vaginal | NA | High-grade leiomyosarcoma | Chemotherapy | Nodal metastasis (PET-CT) | Rec of pelvic mass at 2 years | |
| Grigoriadis | 1/333 | ||||||||||
| Case 1 | 71 | - | NA | VH | Trans-vaginal | NA | Squamous cell ca of the uterine cervix | NA | NA | NA | |
| Vallabh-Patel | 4/786 | ||||||||||
| Case 1 | NA | NA | None | Robotic-assisted supracervical hysterectomy | Morcellate | 1 | Endometrioid ca, grade 1 | Laparoscopic BSO | None | Disease-free at >5 years | |
| Case 2 | NA | NA | None | Robotic-assisted supracervical hysterectomy | Morcellate | 1 | Endometrioid ca, grade 1 | Trachelectomy, appendectomy | None | Disease-free at >5 years | |
| Case 3 | NA | NA | None | Robotic-assisted supracervical hysterectomy | Morcellate | 1 | Endometrioid ca, Grade 1 | Only pelvic ex | None | Disease-free at >5 years | |
| Case 4 | NA | NA | None | Robotic-assisted supracervical hysterectomy | Morcellate | NA | Serous carcinoma | Laparoscopic BSO, trachelectomy, partial mesh removal, and CT | NA | Disease-free at >2.5 years | |
| Ackenbom | 3/1196 | ||||||||||
| Case 1 | NA | NA | NA | VH | Trans-vaginal | NA | Endometrioid ca | NA | NA | NA | |
| Case 2 | NA | NA | NA | VH | Trans-vaginal | NA | Endometrioid ca | NA | NA | NA | |
| Case 3 | NA | NA | NA | VH | Trans-vaginal | NA | Endometrioid ca | NA | NA | NA | |
| Mizrachi | 1/667 | ||||||||||
| Case 1 | 65 | - | None | VH, PFR | Trans-vaginal | 1A | Endometrioid ca, Grade 1 | None | NA | Disease-free at >10 years |
FIGO: The International Federation of Gynecology and Obstetrics, NA: Not available, BSO: bilateral salpingo-oophorectomy, CT: Chemotherapy, VH: Vaginal hysterectomy, PFR: pelvic floor repair, TVT: Tension-free vaginal tape, PLNDx: Pelvic lymph nodes dissection, NED: No evidence of disease DOD: Died of disease